HIGHFDA DRUG

Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60 Tablets per Bottle, Rx only, Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc.,...

CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
June 12, 2026
Status
ACTIVE

Quick Facts at a Glance

Recall Date
June 12, 2026
Hazard Level
HIGH
Brand
Boehringer Ingelheim Pharmaceuticals
Geographic Scope
1 states

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Boehringer Ingelheim Pharmaceuticals
Model numbers
Lot 3244413, Exp. 12/31/2028
Where affected
OH

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    June 12, 2026

  2. Reported by FDA DRUG

    July 8, 2026

  3. RecallRadar source check

    July 14, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Boehringer Ingelheim Pharmaceuticals, Inc. or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Boehringer Ingelheim Pharmaceuticals recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Full Description

Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60 Tablets per Bottle, Rx only, Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA. NDC: 00597-0300-45. Reason: CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.. Classification: Class II. Quantity: 560 bottles. Distribution: OH

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: How to Get Refunds and Replacements

Want to Know First?

Get instant alerts for recalls that affect you. Free forever.

Product Classification

Product Details

Model Numbers
Lot 3244413
Exp. 12/31/2028
Affected States
OH
Report Date
July 8, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE